Sectors
MREO
Mereo BioPharma Group plc
0.27
2 x 0.18
2 x 0.34
bid
ask
+
0.02
7.25%
02:09 PM
timesize
| Ytd | -35.06% | |
| 1y | -84.16% |
0.25
day range
0.29
0.20
52 week range
2.37
| Open | 0.25 | Prev Close | 0.25 | Low | 0.25 | High | 0.29 | Mkt Cap | 43.24M |
| Vol | 1.19M | Avg Vol | 4.34M | EPS | -0.20 | P/E | N/A | Forward P/E | -113.00 |
| Beta | 0.36 | Short Ratio | 8.10 | Inst. Own | 70.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 0.31 | 200-d Avg | 0.61 | 1yr Est | 7.04 |
| Income Statement | |||
| Operating Expenses | 7.03M | ||
| Research and Development Expense | 1.81M | ||
| Selling, General and Administrative Expense | 5.22M | ||
| Operating Income | -7.03M | ||
| Interest Expense | 16.00K | ||
| Income Tax Expense | -119.00K | ||
| Net Income | -7.00M | ||
| Net Income Common Stock | -7.00M | ||
| Net Income Common Stock (USD) | -7.00M | ||
| Consolidated Income | -7.00M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -7.11M | ||
| Earning Before Interest & Taxes (USD) | -7.11M | ||
| Weighted Average Shares | 803.56M | ||
| Weighted Average Shares Diluted | 803.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.12M | ||
| Cash and Equivalents (USD) | 30.12M | ||
| Current Assets | 33.40M | ||
| Property, Plant & Equipment Net | 1.06M | ||
| Total Assets | 34.71M | ||
| Debt Current | 1.03M | ||
| Total Debt | 1.03M | ||
| Current Liabilities | 5.68M | ||
| Total Liabilities | 6.06M | ||
| Accumulated Retained Earnings (Deficit) | -514.54M | ||
| Accumulated Other Comprehensive Income | -12.28M | ||
| Shareholders Equity | 28.65M | ||
| Shareholders Equity (USD) | 28.65M | ||
| Assets Non-Current | 1.31M | ||
| Total Debt (USD) | 1.03M | ||
| Goodwill and Intangible Assets | 256.00K | ||
| Liabilities Non-Current | 385.00K | ||
| Trade and Non-Trade Payables | 1.12M | ||
| Tax Assets | 1.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 299.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.04M | ||
| Net Cash Flow from Operations | -6.04M | ||
| Effect of Exchange Rate Changes on Cash | -62.00K | ||
| Share Based Compensation | 1.32M | ||